cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation?
oleh: Nicola Normanno, Antonella De Luca, Francesco Perrone
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2020-07-01 |
Deskripsi
No description available for this item.